AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy
AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy
Not yet recruiting · NCT07118735 · Registry updated 2025-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver cancer, liver disorder, neoplasm | Not yet recruiting | Not applicable | 2025-08-12 | NCT07118735 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cheng-Kung University Hospital | 83 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No. 138, Shengli Rd., North Dist | Tainan | Taiwan | 1 |